These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19467276)

  • 21. Transdermal enhancement effect and mechanism of iontophoresis for non-steroidal anti-inflammatory drugs.
    Zuo J; Du L; Li M; Liu B; Zhu W; Jin Y
    Int J Pharm; 2014 May; 466(1-2):76-82. PubMed ID: 24607207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations.
    Cevc G; Mazgareanu S; Rother M; Vierl U
    Int J Pharm; 2008 Jul; 359(1-2):190-7. PubMed ID: 18499370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QSPR study of polychlorinated diphenyl ethers by molecular electronegativity distance vector (MEDV-4).
    Sun L; Zhou L; Yu Y; Lan Y; Li Z
    Chemosphere; 2007 Jan; 66(6):1039-51. PubMed ID: 16919308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A two-layer diffusive model for describing the variability of transdermal drug permeation.
    Meidan VM; Pritchard D
    Eur J Pharm Biopharm; 2010 Mar; 74(3):513-7. PubMed ID: 20005948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative structure-property relationships (QSPR) for steroidal compounds of environmental importance.
    Cao Q; Garib V; Yu Q; Connell DW; Campitelli M
    Chemosphere; 2009 Jul; 76(4):453-9. PubMed ID: 19394998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study.
    Wang JJ; Sung KC; Huang JF; Yeh CH; Fang JY
    J Pharm Pharmacol; 2007 Jul; 59(7):917-25. PubMed ID: 17637185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation.
    Watkinson RM; Guy RH; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2009; 22(4):225-30. PubMed ID: 19648784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of drug partition property in artificial sebum.
    Valiveti S; Wesley J; Lu GW
    Int J Pharm; 2008 Jan; 346(1-2):10-6. PubMed ID: 17651932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The delivery of ketoprofen from a system containing ion-exchange fibers.
    Yu L; Li S; Yuan Y; Dai Y; Liu H
    Int J Pharm; 2006 Aug; 319(1-2):107-13. PubMed ID: 16701973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal behaviour of the N-alkylamide spilanthol (affinin) from Spilanthes acmella (Compositae) extracts.
    Boonen J; Baert B; Roche N; Burvenich C; De Spiegeleer B
    J Ethnopharmacol; 2010 Jan; 127(1):77-84. PubMed ID: 19808085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating skin permeability from physicochemical characteristics of drugs: a comparison between conventional models and an in vivo-based approach.
    Farahmand S; Maibach HI
    Int J Pharm; 2009 Jun; 375(1-2):41-7. PubMed ID: 19481689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
    Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
    Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excised porcine skin experimental systems to validate quantitative microdialysis methods for determination of drugs in skin after topical application.
    Seki T; Wang A; Yuan D; Saso Y; Hosoya O; Chono S; Morimoto K
    J Control Release; 2004 Nov; 100(2):181-9. PubMed ID: 15544866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations.
    So JW; Park HH; Lee SS; Kim DC; Shin SC; Cho CW
    Drug Deliv; 2009 Jan; 16(1):52-6. PubMed ID: 19555309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New tools and approaches for predicting skin permeability.
    Degim IT
    Drug Discov Today; 2006 Jun; 11(11-12):517-23. PubMed ID: 16713903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designing for topical delivery: prodrugs can make the difference.
    Sloan KB; Wasdo S
    Med Res Rev; 2003 Nov; 23(6):763-93. PubMed ID: 12939791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in predicting skin permeability of hydrophilic solutes.
    Chen L; Han L; Lian G
    Adv Drug Deliv Rev; 2013 Feb; 65(2):295-305. PubMed ID: 22580335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal drug delivery systems: skin perturbation devices.
    Brown MB; Traynor MJ; Martin GP; Akomeah FK
    Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS.
    Perioli L; Ambrogi V; Bernardini C; Grandolini G; Ricci M; Giovagnoli S; Rossi C
    Eur J Med Chem; 2004 Aug; 39(8):715-27. PubMed ID: 15276305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphatidylcholine embedded micellar systems: enhanced permeability through rat skin.
    Spernath A; Aserin A; Sintov AC; Garti N
    J Colloid Interface Sci; 2008 Feb; 318(2):421-9. PubMed ID: 18005978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.